top of page
G
This funding opportunity is for clinical trials that test new or improved treatments for rare brain and nerve diseases in kids and adults. The goal is to find out if these treatments are safe and effective. By supporting smart, cooperative, and innovative studies, the FDA hopes more treatments for these rare diseases can be approved. This will help patients who currently have few or no options and also improve how new drugs for rare diseases are developed in the future.
Full Description
the purpose of this notice of funding opportunity (nofo) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare neurodegenerative diseases for children and adults. through the support of collaborative, efficient, and/or innovative clinical trials, fda expects to increase the number of approved treatments for rare neurodegenerative diseases and exert a broad and positive impact on rare disease drug development.
If you want to feel more confident about your application, we're here. Reach out anytime!
bottom of page